Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00016783 · ClinicalTrials.gov registry record
Stopping and Restarting Anti-HIV Drugs in Children and Adolescents With Low Blood Levels of HIV
A clinical trial, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- 39
- Enrollment target
NCT00016783 is a clinical trial that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 39 participants.
The verdict
NCT00016783 has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- 39 participants
- Enrollment target
Study Summary
Some patients taking anti-HIV drugs as part of highly active antiretroviral therapy (HAART) do not show any HIV in the blood; however, some HIV will remain hidden in the body and, if the drugs are stopped, will return to the blood. The purpose of this study is to determine if short periods of stopping HAART increase the activity of CD8 and CD4 cells (cells of the immune system that fight infection), if repeated stopping of these drugs for longer periods of time and restarting them will increase effectiveness of HAART, and if the increased immune system activity as a result of stopping treatment leads to lower levels of HIV over time.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Est. Completion | 2006-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00016783
The ClinicalTrials.gov registry entry for NCT00016783 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00016783 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00016783 about?
NCT00016783 is a clinical study titled "Stopping and Restarting Anti-HIV Drugs in Children and Adolescents With Low Blood Levels of HIV". Some patients taking anti-HIV drugs as part of highly active antiretroviral therapy (HAART) do not show any HIV in the blood; however, some HIV will remain hidden in the body and, if the drugs are stopped, will return to the blood. The purpose of this study is to determine if short periods of stoppi...
What is the current status of trial NCT00016783?
This trial is currently completed. The enrollment target is 39 participants. Estimated completion is 2006-10.
Who is sponsoring clinical trial NCT00016783?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.